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M/48F,age:71 + 9 yrs)followedupfmmdischargeupto September30th,
1995(medianfollow-up:18.4months,range:3 daye-4.7yeare).At entry,
61 hadclaudicetionintermittent(Cl),94 criticallimbischemia(painat rest
and/ortrophic lesions,CLI) and 23 isolatedabdominalaorticaneurysms
(AAA).At the end of follow-up,49 deaths(N =41 CV accordingto death
certificate) were recorded,36 (i’s~o) in ptson CLI, 12 (25~o) in Cl and 1
(2%)inAAA(p < OIJOOl).Whencomparedwithsurvivors(n= 129),dead(n
= 49)wereelightlyolder(72 + 9 vs 70 + 9 yrs,p < 0.04),morefrequently
diabetics(38°Avs 22’%.,p < 0.08)withhi~herfibrinogen(459+ 165vs369
+ 127rng/dl,p -=0.0003)and leukocytes(8.4+ 3 vs 7.5 + 2 x IOg/L,p
< 0.03) levels.Sex distribution(i’z~. vs 80Y0males),systolicBP (160&
22 vs 163 & 21 mmHg),total cholesterol(208+ 43 ve 201 & 46 mg/dl),
triglycerides(155+ S3vs 162*71 rn@dl)did notdiffer.Ptswithfibrinogen
levelsin the higherquarlile(>472 mddl, n = 45)diedmorefrequently(40%
vs 17%,p < 0,01) thanthosein the lowerone (<290 m@dl,n = 4S);the
prevalenceof ptson CLI(44%vs3S%),diabetics(30%va 18%)andactual















ever,few atudieshavedeterminedthe prevalenceof aPl in an unselected
populationwithperipheralvaaculardleeaaa(PVD).Weprospectivelystudied
253 consecutivepts with PVD(60 + 11.4years (mean* SD))and 100
matchedcontrols(58.7+ 11.2yeare).Theprevalenceof aPlwas18.2Y0in
pteand9%incontrola(p <0.03, anticsrdioiipinantibodies:lgG:14.2vs7%,
lgM: 3.2 vs 2Y0,lupusanticoagulant:2 vs O%in ptsand controla,respec-
tively).Riskfactorsfor atheroscleroeiawereequallydistributedamongpts
with aPi (aPI+,n = 46) and pts withoutaPl (aPI- n = 207).Angiogrephic
lesionswereaimilarin the 2 groupsexceptfor infrarenalaorticthromlxrais
whichoccurredin 6,5Y0of aPl+and in 1%of aP1- (p = 0.02).A historyof
deepvein thrombosis(10.9vs 3%, p < 0.05),of stroke(11vs 5.3%),of
coronaryartetydisease(32.6vs20.3%),of haaledcancer(8.7vs2.4%,p <
0.05),Iivado(4.3vs 1°%p c 0.05)andRaynaud’sphenomenon(13vs 1%,
p < 0.001)weremorefrequentin aPl+thanaP1-. In multlvariateanalysis,
the presenceof aPl wassignificantlyasmoiatedwith Iivsdo(F = 93.1,p <
0.0001),historyof cancer(F= 19.4,p < 0.0001),of coronswarterydisease
(F= 16, p < 0.0001)and of deepvein thrombosis(F = 6.8, p e 0.01).In










vasadilatationis impairedIn experimentalpulmonaryembolism(PE). To
atudytherelationshipbetweenthedegreeof impairmentandthe severityof
PE,pulmonaryvsaoreactivitywasexaminedinsubmissive(SM;n= 11)and
massive(M;n = 11)PEin 22 mongreldogsby intrapulmonaryinfusionsof
acstylcholine(ACh)and nitroglycerin(TNG).Selectedcine angiogramsof
a segmentalpulmonaryartary(PA)wereobtainedafter infusionof graded
concentrationsof ACh (10-9 to 10-5M) followedby an infusionof TNG
(40pg)intothe PAbeforeandafterPE.Percentchangein PAdiameterwas
meeauredusingquantitativeangiogrephy.Doseresponsecurvesobtained
fmmmeanvaluesforcontrol,SMand M PEwitheachinfusionof ACHand
TNGaredisplayed.ACH-mediatedpulmonaryvasodilatationis impairedin











OurInstitutehasstudiedthe largestnumberof oaseaof Takayasu’sdisease
in India.550 cases(Male:Female= 1:6.4),age rangeS3S years were
studiedfor last 17 yeara(1978-1995).Hospitalrecordawereanalyaedfor
clinicalparameters,echocardiographic,angiographicfindingsandfollow-up
data.5.8Y0patientspresentedwithsymptomaof activediseaseandthe rest
presentedwith featuresof chmfic disease.Baaedon aortogrephy,type-l
aortoarteritiswasseenin 16%,type-nin 8%andtype-ill in 76%.Pulmonary
involvementwasfoundin 36%andcoronatyinvolvementin 10%patienta.
Afterestablishmentof diagnosisandinitialhighdosesteroidtherapy,all
patientsreceivedlowdosesteroid(Prednisolone2.5 mgfdayfor 2-5 years).



















syndromeshas been linkedto the AM peak in prothromboticforceswith
resultingocclusivethrombusformationperhapsat the site of a ruptured
plaque.Indeed,antiplateletagentshavebeenshownto reducetheAMpeak
intheonsetof acutemyocerdialinfarctionin the PhysiciansHealthStudy.
